Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery

Powder Technology

Volumn 182, Issue 1, 2008, Pages 25-32

  Kim, Yong Ho ^a   Shing, Katherine S ^a  

^a University of Southern California ^*  (United States)

Author keywords

Aerodynamic diameter; Aerosol solvent extraction system; Ipratropium bromide; Pulmonary delivery; Supercritical antisolvent

Indexed keywords

ACETONE; AERODYNAMICS; AEROSOLS; COBALT COMPOUNDS; DIMETHYLFORMAMIDE; ETHANOL; EXTRACTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLVENTS;

AERODYNAMIC DIAMETER; AEROSOL SOLVENT EXTRACTION SYSTEM; IPRATROPIUM BROMIDE; PULMONARY DELIVERY; SUPERCRITICAL ANTISOLVENT;

DRUG DELIVERY;

ALCOHOL; IPRATROPIUM BROMIDE; N,N DIMETHYLFORMAMIDE;

ACETONE; AERODYNAMICS; AEROSOLS; COBALT COMPOUNDS; DIMETHYLFORMAMIDE; DRUG DELIVERY; ETHANOL; EXTRACTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLVENTS;

AEROSOL; ARTICLE; DENSITY; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; PARAMETER; PARTICLE SIZE; PRESSURE; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; SUPERCRITICAL FLUID; TEMPERATURE;

EID: 38649129879     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2007.04.009     Document Type: Article

References (41)

1. Malcolmson R.J., and Embleton J.K. Dry powder formulations for pulmonary delivery. Pharm. Sci. Technol. Today (PSTT) 1 (1998) 394-398
2. Timsina M.P., Martin G.P., Marriott C., Ganderton D., and Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101 (1994) 1-13
3. Agu R.U., Ugwoke M.I., Armand M., Kinget R., and Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2 (2001) 198-209
4. Smith S.J., and Bernstein J.A. Therapeutic uses of lung aerosols. In: Hickey A.J. (Ed). Inhalation Aerosols: Physical And Biologic Basis for Therapy (1996), Marcel Dekker, Inc., New York 233-269
5. Tu L.S., Dehghani F., and Foster N.R. Micronisation and microencapsulation of pharmaceuticals using a carbon dioxide antisolvent. Powder Technol. 126 (2002) 134-149
6. Hickey A.J., and Dunbar C.A. A new millennium for inhaler technology. Pharm. Technol. 21 (1997) 116-125
7. Shekunov B.Y. Production of powder for respiratory drug delivery. In: York P., Kompella U.B., and Shekunov B.Y. (Eds). Supercritical Fluid Technology for Drug Product Development (2004), Marcel Dekker, Inc., New York 247-282
8. Subramaniam B., Rajewski R.A., and Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci. 86 (1997) 885-890
9. Reverchon E., and Porta G.D. Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation. Powder Technol. 106 (1999) 23-29
10. Reverchon E. Supercritical antisolvent precipitation of micro- and nano-particles. J. Supercrit. Fluids 15 (1999) 1-21
11. Foster N.R., Mammucari R., Dehghani F., Barrett A., Bezanehtak K., Coen E., Combes G., Meure L., Ng A., Regtop H.L., and Tandya A. Processing pharmaceutical compounds using dense gas technology. Ind. Eng. Chem. Res. 42 (2003) 6476-6493
12. Dehghani F., and Foster N.R. Dense gas anti-solvent processes for pharmaceutical formulation. Curr. Opin. Solid State Mater. Sci. 7 (2003) 363-369
13. Fages J., Lochard H., Letourneau J.-.J., Sauceau M., and Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol. 141 (2004) 219-226
14. Reverchon E., and Spada A. Erythromycin micro-particles produced by supercritical fluid atomization. Powder Technol. 141 (2004) 100-108
15. Jaarno S., Rantakyla M., and Aaltonen O. Particle tailoring with supercritical fluids: production of amorphous pharmaceutical particles. Proceedings of the 4th International Symposium on Supercritical Fluids, Sendai, Japan (May 11-14 1997)
16. Reverchon E., Porta G..D., and Pallado P. Supercritical antisolvent precipitation of salbutamol microparticles. Powder Technol. 114 (2001) 17-22
17. Shekunov B.Y., Feeley J.C., Chow A.H.L., Tong H.H.Y., and York P. Aerosolisation behaviour of micronised and supercritically-processed powders. J. Aerosol Sci. 34 (2003) 553-568
18. Rehman M., Shekunov B.Y., York P., Lechuga-Ballesteros D., Miller D.P., Tan T., and Colthorpe P. Optimisation of powders for pulmonary delivery using supercritical fluid technology. Eur. J. Pharm. Sci. 22 (2004) 1-17
19. Reverchon E., and Porta G.D. Terbutaline microparticles suitable for aerosol delivery produced by supercritical assisted atomization. Int. J. Pharm. 258 (2003) 1-9
20. Steckel H., Thies J., and Müller B.W. Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide. Int. J. Pharm. 152 (1997) 99-110
21. Velaga S.P., Berger R., and Carlfors J. Supercritical fluids crystallization of budesonide and flunisolide. Pharm. Res. 19 (2002) 1564-1571
22. Steckel H., Pichert L., and Müller B.W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 57 (2004) 507-512
23. Bleich J., Müller B.W., and Waβmus W. Aerosol solvent extraction system - a new microparticle production technique. Int. J. Pharm. 97 (1993) 111-117
24. Bleich J., Kleinebudde P., and Müller B.W. Influence of gas density and pressure on microparticles produced with the ASES process. Int. J. Pharm. 106 (1994) 77-84
25. Bleich J., and Müller B.W. Production of drug loaded microparticles by the use of supercritical gases with the Aerosol Solvent Extraction System (ASES) process. J. Microencapsul. 13 (1996) 131-139
26. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., and Avery G.S. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20 (1980) 237-266
27. Hogan T.J., Geddes R., and Gonzalez E.R. An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease. Clin. Ther. 25 (2003) 285-297
28. Hinds W.C. Aerosol technology-properties, behavior, and measurement of airborne particles. 2nd ed. (1999), John Wiley & Sons, New York 42-110
29. Findeisen W. Über das Absetzen Kleiner, in der Luft suspendierter Teilchen in der menschlichen Lunge bei der Atmung. Pflügers Arch. D. Gesamte Physiol. 236 (1935) 367-379
30. Landahl H.D. On the removal of air-borne droplets by human respiratory tract. I. The lung. Bull. Math. Biophys. 12 (1950) 43-56
31. Phalen R.F., Cuddihy R.G., Fisher G.L., Moss O.R., Schlesinger R.B., Swift D.L., and Yeh H.C. Main features of the proposed NCRP respiratory tract model. Rad. Prot. Dos. 38 (1991) 179-184
32. Bair W.J. Overview of ICRP respiratory tract model. Rad. Prot. Dos. 38 (1991) 147-152
33. Asgharian B., Hofmann W., and Bergmann R. Particle deposition in a multiple-path model of the human lung. Aerosol Sci. Technol. 34 (2001) 332-339
34. Yeh H.-C., Schum G.M., and Duggan M.T. Anatomic models of the traceobronchial and pulmonary regions of the rat. Anat. Rec. 195 (1979) 483-492
35. Boutin O., Badens E., Carretier E., and Charbit G. Co-precipitation of a herbicide and biodegradable materials by the supercritical anti-solvent technique. J. Supercrit. Fluids 31 (2004) 89-99
36. Warwick B., Dehghani F., Foster N.R., Biffin J.R., and Regtop H.L. Micronization of copper indomethacin using gas antisolvent processes. Ind. Eng. Chem. Res. 41 (2002) 1993-2004
37. Werling J.O., and Debenedetti P.G. Numerical modeling of mass transfer in the supercritical antisolvent process: miscible conditions. J. Supercrit. Fluids 18 (2000) 11-24
38. Martin A., and Cocero M.J. Numerical modeling of jet hydrodynamics, mass transfer, and crystallization kinetics in the supercritical antisolvent (SAS) process. J. Supercrit. Fluids 32 (2004) 203-219
39. Angus S., Armstrong B., and de Reuck K.M. International Thermodynamic Tables of the Fluid State Carbon Dioxide. 1st ed. (1976), Pergamon Press, New York 338
40. Silverstein R.M., Bassler G.C., and Morrill T.C. Spectrometric Identification of Organic Compounds. 5th ed. (1991), John Wiley & Sons, Inc., New York 91-164
41. Zanen P., Go L.T., and Lammers J.-W.J. The optimal particle size for parasympathicolytic aerosols in mild asthmatics. Int. J. Pharm. 114 (1995) 111-115